Shengmai San
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Shengmai San, covering 2024-01-19 to 2024-01-19. Get the full timeline:
Most recent: Clinical Trial Update: The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity [Phase 3]